ABCG2 and familial pancreatic carcinoma: As no effective approaches for curing pancreatic cancer exist at present, we propose that gene therapy targeting hsa-miR-520h/ABCG2 should be investigated further as a potential alternative therapeutic strategy for pancreatic cancer.